CN Patent

CN106349132B — 沃替西汀中间体杂质及其制备方法和用途

Assigned to Zhien Biotechnology Co.,Ltd. · Expires 2018-02-02 · 8y expired

What this patent protects

本发明公开了沃替西汀杂质，即沃替西汀杂质1、杂质2、杂质3、杂质4、杂质5、杂质6；上述六种杂质均为首次发现的新化合物，此外，还公开了其制备方法。本发明提供的沃替西汀相关杂质作为沃替西汀中间体、原料药及其复方制剂质量研究的对照品的用途，为沃替西汀的质量研究夯实了基础。

USPTO Abstract

本发明公开了沃替西汀杂质，即沃替西汀杂质1、杂质2、杂质3、杂质4、杂质5、杂质6；上述六种杂质均为首次发现的新化合物，此外，还公开了其制备方法。本发明提供的沃替西汀相关杂质作为沃替西汀中间体、原料药及其复方制剂质量研究的对照品的用途，为沃替西汀的质量研究夯实了基础。

Drugs covered by this patent

vortioxetine-hydrobromide (VORTIOXETINE HYDROBROMIDE)

Patent Metadata

Patent number: CN106349132B
Jurisdiction: CN
Classification: —
Expires: 2018-02-02
Drug substance claim: No
Drug product claim: No
Assignee: Zhien Biotechnology Co.,Ltd.
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.